(Q37076360)

18 August 2017

1 reference

title

Polymeric nanoparticles for the drug delivery to the central nervous system (English)

1 reference

18 August 2017

0 references

1 reference

0 references

Barbara Ruozi

3

0 references

Luca Costantino

Luca Costantino

2

0 references

Flavio Forni

Flavio Forni

4

0 references

Maria Angela Vandelli

Maria Angela Vandelli

5

0 references

Giovanni Tosi

Giovanni Tosi

1

0 references

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Expert Opinion on Drug Delivery

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

155-174

1 reference

A review of nanocarrier-based CNS delivery systems

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Occludin expression in microvessels of neoplastic and non-neoplastic human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Vascular microenvironment in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug delivery systems for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug and gene targeting to the brain with molecular Trojan horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeted delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanomedicine--prospective therapeutic and diagnostic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug delivery strategies for poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Multifunctional nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug targeting systems for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanoparticles--a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Blood-brain barrier delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug transport to brain with targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanoparticle technology for delivery of drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

New technologies for drug delivery across the blood brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

In vitro model for the degradation of alkylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Applications of magnetic nanoparticles in biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Medical application of functionalized magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Distribution of small magnetic particles in brain tumor-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanogels for oligonucleotide delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

In situ blood-brain barrier transport of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Brain uptake of thiamine-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Paclitaxel nanoparticles for the potential treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Reversal of multidrug resistance by surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Polymer-coated long-circulating microparticulate pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

A methodology to study intracellular distribution of nanoparticles in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Accelerated clearance of a second injection of PEGylated liposomes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Advances in strategies to improve drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: possible function in insulin processing in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Transferrin-antibody fusion proteins are effective in brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Human blood-brain barrier transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Studies of macromolecular prodrugs of zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Synthesis of pegylated immunonanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Insulin and insulin receptors in rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Blood-brain barrier transcytosis of insulin in developing rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Kinetics of thiamine transport across the blood-brain barrier in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Bioavailability and transport of peptides and peptide drugs into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Development of neuropeptide drugs that cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Glycosylated neuropeptides: a new vista for neuropsychopharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Glycosylation improves the central effects of DAMGO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.155

21 January 2018

Identifiers

DOI

10.1517/17425247.5.2.155

1 reference

18 August 2017

1 reference